Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin

Coldiron, Matthew E.; Gutierrez Zamudio, Ana Gabriela; Manuel, Rolanda; Luciano, Gilda; Rusch, Barbara; Ciglenecki, Iza; Telnov, Alex; Grais, Rebecca F.; Toutous Trellu, Laurence Marie; Molfino, Lucas

doi:10.1186/s13027-020-00341-4

Scientific article

English

Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin

ContributorsColdiron, Matthew E.; Gutierrez Zamudio, Ana Gabriela; Manuel, Rolanda; Luciano, Gilda; Rusch, Barbara; Ciglenecki, Iza; Telnov, Alex; Grais, Rebecca F.; Toutous Trellu, Laurence Marie

; Molfino, Lucas

Published inInfectious Agents and Cancer, vol. 16, no. 1

Publication date2021

Keywords

AIDS-related opportunistic infections
Acquired immunodeficiency syndrome
Doxorubicin
Kaposi sarcoma
Mozambique

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

COLDIRON, Matthew E. et al. Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin. In: Infectious Agents and Cancer, 2021, vol. 16, n° 1. doi: 10.1186/s13027-020-00341-4

Article (Published version)

CC BY

Identifiers

PID : unige:150520
DOI : 10.1186/s13027-020-00341-4
PMID : 33413521

Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791748/

Journal ISSN1750-9378

447views

392downloads

Creation19/03/2021 09:31:00

First validation19/03/2021 09:31:00

Update13/10/2025 16:29:34

Status update24/01/2025 15:51:29

Last indexation20/10/2025 22:02:50

Archive ouverte UNIGE

Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin

Technical informations